Business Today
Subscribe
PMS TodayUS NewsIndiaUPSTARTWeatherBT ShortsNRIEducationElection
BT India 100BT GolfBT Mindrush
Search

COMPANIES

No Data Found

NEWS

No Data Found
Advertisement
News
markets
stocks
Novartis India Ltd
Novartis India Ltd

Novartis India Ltd (NOVARTIND) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 11,837
Oct 25, 2023 Closed
  • NSE
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹672.25
₹0.00 (0.00%)
668.35Low
Today’s Performance
698.20High
-Low
52 Week’s Performance
698.20High

bt_logoStock Analysis

bt_logoStock Performance

  • 1 Day-%
  • 1 Week-6.23%
  • 1 Month-6.85%
  • 3 Months-12.85%
  • 6 Months16.72%
  • 1 Year-1.49%
  • 3 Years2.45%
  • 5 Years-%

bt_logoStock Summary

  • Face Value (₹)5.00
  • Beta-
  • 52-Week Low (₹)-
  • 52-Week High (₹)-
  • Price-to-Book (X)*3.57
  • Dividend Yield (%)2.37
  • Price-to-Earnings (P/E) (X)*-
  • Earnings Per Share (₹)35.40
  • Market Cap (₹ Cr.)*1,659.84
* Values as of last close price

bt_logoCOMPETITORS

BT TV

Business Today India@100 | Richard Rossow On India’s Strategy To Become A Global Power By 204731:24Business Today India@100 | Richard Rossow On India’s Strategy To Become A Global Power By 2047
Business Today India@100 | NITI Aayog’s Dr Arvind Virmani On India’s Roadmap To Viksit Bharat 204730:20Business Today India@100 | NITI Aayog’s Dr Arvind Virmani On India’s Roadmap To Viksit Bharat 2047
DCB Bank Q1FY26 | Net Profit Up 20% At Rs 157 Cr | Top Management Excl25:12DCB Bank Q1FY26 | Net Profit Up 20% At Rs 157 Cr | Top Management Excl
Tuhin Kanta Pandey: SEBI to Enforce '@valid' UPI for Safer Market Transactions from Oct 11:48Tuhin Kanta Pandey: SEBI To Enforce '@valid' UPI For Safer Market Transactions From Oct 1
Ambuja Cements Q1FY26: Record Revenue, EBITDA, Market Share Gains | Top Mgmt On Growth Plans6:56Ambuja Cements Q1FY26: Record Revenue, EBITDA, Market Share Gains | Top Mgmt On Growth Plans
Trump’s Tariff Tsunami: Wave Of New Duties Hits 69 Countries4:05Trump’s Tariff Tsunami: Wave Of New Duties Hits 69 Countries
Philips Ramps Up India Expansion15:45Philips Ramps Up India Expansion
EXPLAINED: India-Russia Oil & Energy Ties Which Face Trump Threats5:14EXPLAINED: India-Russia Oil & Energy Ties Which Face Trump Threats
Rahul Gandhi: Election Commission Is BJP’s ‘Vote Theft Branch’, Says Proof Coming Soon2:13Rahul Gandhi: Election Commission Is BJP’s ‘Vote Theft Branch’, Says Proof Coming Soon
IndusInd Probe, F&O Expiry, Jane Street, Vedanta: Big Questions For SEBI Chief Tuhin Kanta Pandey3:20IndusInd Probe, F&O Expiry, Jane Street, Vedanta: Big Questions For SEBI Chief Tuhin Kanta Pandey
View more

bt_logoFAQ's

What was Novartis India Ltd share price previously?
Novartis India Ltd share price was down by 0.00% from the previous closing price of ₹672.25.
Who are peers of Novartis India Ltd?
The peers of Novartis India Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Torrent Pharmaceuticals Ltd, Cipla Ltd, Mankind Pharma Ltd, Dr Reddys Laboratories Ltd, Zydus Lifesciences Ltd.
Who is/are the promoter/promoters of Novartis India Ltd?
The promotor/promotors of Novartis India Ltd are C Snook, Sandra Martryes, SANKER PARAMESWARAN, Shilpa Joshi, Chandni Maru, Gira Sardesai, Falin Majmudar.
What has been 52-week high of Novartis India Ltd stocks?
The highest price of Novartis India Ltd stock is ₹0.00 in the last 52-week.
What is the share price of Novartis India Ltd (NOVARTIND) today on NSE?
As on Oct 25, 2023 Novartis India Ltd (NOVARTIND)’s share price on NSE is Rs 672.25
What is the market cap of Novartis India Ltd (NOVARTIND)?
The current market capitalisation of Novartis India Ltd (NOVARTIND) is 1,659.84 crores
What is Novartis India Ltd Share symbol?
The symbol of Novartis India Ltd is NOVARTIND.
What is the PE ratio of Novartis India Ltd (NOVARTIND)?
The current PE ratio of Novartis India Ltd (NOVARTIND) is -.
What is the PB ratio of Novartis India Ltd (NOVARTIND)?
The current PB ratio of Novartis India Ltd (NOVARTIND) is 3.57.
Today’s High & Low share prices of Novartis India Ltd (NOVARTIND) on NSE?
Today, the share price of Novartis India Ltd (NOVARTIND) on NSE touched a high of Rs 698.2 and a low of Rs 668.35
What price did Novartis India Ltd (NOVARTIND) shares open on the NSE today?
On NSE, the share price of Novartis India Ltd (NOVARTIND) opened at Rs 691.05
What is the 52-week high of Novartis India Ltd (NOVARTIND)?
The 52-week high price of Novartis India Ltd (NOVARTIND) is Rs 698.20
What is the 52-week low of Novartis India Ltd (NOVARTIND)?
The 52-week low price of Novartis India Ltd (NOVARTIND) is Rs -

bt_logoAbout Novartis India

Novartis India Ltd, incorporated in the year 1947, has its registered office in The Inspire BKC Part 601 & 701, Bandra Kurla Complex Bandra(E), Mumbai, Maharashtra, 400051, 91-022-50243000, 91-022-50243010. The main industry in which Novartis India Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

Auditor/Auditors for Novartis India Ltd is/are B S R & Co LLP. In the main management, C Snook is chairman and Chandni Maru is the company secretary for Novartis India Ltd.

  • CS
    C SnookChairman (Non-Executive)
  • SM
    Sandra MartryesIndependent Director
  • SP
    SANKER PARAMESWARANIndependent Director
  • SJ
    Shilpa JoshiWhole Time Director & Chief Financial Officer
  • CM
    Chandni MaruCompany Sec. & Compli. Officer
  • GS
    Gira SardesaiIndependent Director
  • FM
    Falin MajmudarWhole Time Director

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.